Key result
Losartan treatment significantly decreased right ventricular systolic pressure, ACE, and AngII levels, and increased ACE2 expression in rats with smoking-induced pulmonary arterial hypertension (P<0.05).
Why the study?
Does losartan reduce right ventricular systolic pressure and alter RAAS protein expression in a rat model of smoking-induced pulmonary arterial hypertension?
Does losartan reduce right ventricular systolic pressure and alter RAAS protein expression in a rat model of smoking-induced pulmonary arterial hypertension?
p-value: p=<0.05
Losartan attenuates smoking-induced pulmonary arterial hypertension in rats by modulating the expression of ACE and ACE2 in lung tissue.
Hypothesis-generating for RAAS inhibition in smoke-induced PAH; should not yet change clinical practice.
OBJECTIVES: To explore the role of the renin-angiotensin-aldosterone system (RAAS) in the pathogenesis of pulmonary arterial hypertension (PAH) induced by chronic exposure to cigarette smoke. METHODS: 48 healthy male SD rats were randomly divided into four groups (12/group): control group (group A); inhibitor alone group (group B); cigarette induction group (group C); cigarette induction + inhibitor group (group D). After the establishment of smoking-induced PAH rat model, the right ventricular systolic pressure (RVSP) was detected using an inserted catheter; western blotting was used to detect the protein expression of angiotensin-converting enzyme-2 (ACE2) and angiotensin-converting enzyme (ACE); expression levels of angiotensin II (AngII) in lung tissue were measured by radioimmunoassay. RESULTS: After six months of cigarette exposure, the RVSP of chronic cigarette induction group was significantly higher than that of the control group; expression levels of AngII and ACE increased in lung tissues, but ACE2 expression levels reduced. Compared with cigarette exposure group, after losartan treatment, RVSP, ACE and AngII obviously decreased (P<0.05), and ACE2 expression levels significantly increased. CONCLUSION: Chronic cigarette exposure may result in PAH and affect the protein expression of ACE2 and ACE in lung tissue, suggesting that ACE2 and ACE play an important role in the pathogenesis of smoking-induced PAH.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2015) studied smoking-induced pulmonary arterial hypertension (PAH) (n=48). losartan vs. cigarette induction group was evaluated on right ventricular systolic pressure (RVSP), ACE, ACE2, and AngII expression (p=<0.05). Losartan treatment significantly decreased right ventricular systolic pressure, ACE, and AngII levels, and increased ACE2 expression in rats with smoking-induced pulmonary arterial hypertension (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: